P/B
2,4
Biofrontera
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company’s licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company’s licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
$14.4M
Market Cap • 10/9/2026
2015
(11 years)
Founded
2021
(5 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
0,3
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
0,4
EPS
—
Market Cap
Market Cap
14,4M
EV
21,9M
EV/Revenue
0,5
EV/EBITDA
-3,8
EV/EBIT
-3,3
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
0%
Total Yield
0%
Payout
0%
Retained Earnings
-133,3M
Profitability
Gross Margin
79,3%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
6,5%
Capex/Revenue
0%
Capex/D&A
0,4%
Capex/OCF
0%
SBC/OCF
—
% PPE
20,6%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
15,5%
CAGR Op. Income 5Y
-7,6%
CAGR Net Income 5Y
-9,3%
CAGR EPS 5Y
-90,6%
CAGR OCF 5Y
5,7%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
0,2
Quick Ratio
0
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!